Literature DB >> 30156623

High-risk mucosal HPV types associated with squamous cell carcinoma on the nose tip in an immunocompetent young man.

Camila Fátima Biancardi Gavioli1, Cyro Festa Neto1, Stephen K Tyring2, Lana Luiza da Cruz Silva1, Walmar Roncalli Pereira de Oliveira1.   

Abstract

The oncogenic role of high-risk HPV in anogenital, head and neck, and cervical cancer is well recognized, but not in skin cancer in the general population. Some authors have demonstrated their appearance mainly on the hands and feet, particularly in the area of the nail bed, which could be due to contamination with HPV types from anogenital regions. Here, we describe a case of genital HPV associated with SCC on the nose tip in an immunocompetent young man, which was confirmed by histopathological findings and in situ hybridization. The importance of this report is to highlight the potential role of HPV in the etiology of skin cancer in an immunocompetent individual.

Entities:  

Mesh:

Year:  2018        PMID: 30156623      PMCID: PMC6106684          DOI: 10.1590/abd1806-4841.20186919

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  10 in total

Review 1.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

Review 2.  Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis.

Authors:  Jennifer Wang; Bishr Aldabagh; Justin Yu; Sarah Tuttleton Arron
Journal:  J Am Acad Dermatol       Date:  2014-04       Impact factor: 11.527

Review 3.  Ungual and periungual human papillomavirus-associated squamous cell carcinoma: a review.

Authors:  Catherine Riddel; Rashid Rashid; Val Thomas
Journal:  J Am Acad Dermatol       Date:  2011-02-18       Impact factor: 11.527

4.  Squamous cell carcinoma arising in association with verruca vulgares and HPV-2: a clinicopathologic study with p16 and p53 immunohistochemical studies and human papillomavirus in situ hybridization studies.

Authors:  Steven M Ruhoy; Donald G Guinee; Gerard Nuovo
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-04

Review 5.  Increase in head and neck cancer in younger patients due to human papillomavirus (HPV).

Authors:  David Young; Christopher C Xiao; Benjamin Murphy; Michael Moore; Carole Fakhry; Terry A Day
Journal:  Oral Oncol       Date:  2015-06-09       Impact factor: 5.337

6.  Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals.

Authors:  Cinzia Masini; Pawel G Fuchs; Fabrizio Gabrielli; Sabine Stark; Francesco Sera; Miriam Ploner; Carmelo Franco Melchi; Grazia Primavera; Giulio Pirchio; Orietta Picconi; Pierpaolo Petasecca; Maria Sofia Cattaruzza; Herbert J Pfister; Damiano Abeni
Journal:  Arch Dermatol       Date:  2003-07

Review 7.  [HPV infection might play a role in the development of non-melanoma skin cancer in immunocompetent individuals].

Authors:  Fatima Birch-Johansen; Bodil Norrild; Anne Braae Olesen; Allan Jensen; Susanne Krüger Kjær
Journal:  Ugeskr Laeger       Date:  2012-02-13

8.  HPV typing in Brazilian patients with epidermodysplasia verruciformis: high prevalence of EV-HPV 25.

Authors:  Walmar Roncalli P de Oliveira; Qin He; Peter L Rady; Thomas K Hughes; Cyro Festa Neto; Evandro A Rivitti; Stephen K Tyring
Journal:  J Cutan Med Surg       Date:  2004-05-03       Impact factor: 2.092

9.  High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population.

Authors:  Herbert Pfister; Pawel G Fuchs; Slawomir Majewski; Stefania Jablonska; Iwona Pniewska; Magdalena Malejczyk
Journal:  Arch Dermatol Res       Date:  2003-11-15       Impact factor: 3.017

10.  HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression.

Authors:  Renata De Marchi Triglia; Konradin Metze; Luiz Carlos Zeferino; Liliana A Lucci De Angelo Andrade
Journal:  Gynecol Oncol       Date:  2008-11-12       Impact factor: 5.482

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.